Researcher profile
Stefano Fornasaro
Public evidence
2 connected articles
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis.2024 · Europe PMCApplication of Paper-Based Microfluidic Analytical Devices (µPAD) in Forensic and Clinical Toxicology: A Review.2023 · Europe PMC
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.